Vera Therapeutics, Inc. (VERA)

Vera Therapeutics Statistics

Total Valuation

VERA has a market cap or net worth of $3.30 billion. The enterprise value is $2.88 billion.

Market Cap	3.30B
Enterprise Value	2.88B

Important Dates

The next estimated earnings date is Wednesday, February 25, 2026, before market open.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

VERA has 70.99 million shares outstanding. The number of shares has increased by 22.89% in one year.

Current Share Class	70.99M
Shares Outstanding	70.99M
Shares Change (YoY)	+22.89%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	0.84%
Owned by Institutions (%)	72.46%
Float	51.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.45
P/TBV Ratio	8.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.21, with a Debt / Equity ratio of 0.19.

Current Ratio	12.21
Quick Ratio	11.96
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-36.03

Financial Efficiency

Return on equity (ROE) is -73.25% and return on invested capital (ROIC) is -41.18%.

Return on Equity (ROE)	-73.25%
Return on Assets (ROA)	-38.12%
Return on Invested Capital (ROIC)	-41.18%
Return on Capital Employed (ROCE)	-56.81%
Revenue Per Employee	n/a
Profits Per Employee	-$2.25M
Employee Count	112
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, VERA has paid $1,000 in taxes.

Income Tax	1,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +37.28% in the last 52 weeks. The beta is 1.16, so VERA's price volatility has been higher than the market average.

Beta (5Y)	1.16
52-Week Price Change	+37.28%
50-Day Moving Average	41.13
200-Day Moving Average	28.25
Relative Strength Index (RSI)	49.58
Average Volume (20 Days)	1,141,323

Short Selling Information

The latest short interest is 8.46 million, so 11.92% of the outstanding shares have been sold short.

Short Interest	8.46M
Short Previous Month	9.15M
Short % of Shares Out	11.92%
Short % of Float	16.55%
Short Ratio (days to cover)	4.83

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-270.18M
Pretax Income	-251.94M
Net Income	-251.94M
EBITDA	-269.79M
EBIT	-270.18M
Earnings Per Share (EPS)	-$4.00

Balance Sheet

The company has $497.39 million in cash and $77.22 million in debt, with a net cash position of $420.17 million or $5.92 per share.

Cash & Cash Equivalents	497.39M
Total Debt	77.22M
Net Cash	420.17M
Net Cash Per Share	$5.92
Equity (Book Value)	398.88M
Book Value Per Share	6.24
Working Capital	469.43M

Cash Flow

In the last 12 months, operating cash flow was -$210.29 million and capital expenditures -$1.17 million, giving a free cash flow of -$211.47 million.

Operating Cash Flow	-210.29M
Capital Expenditures	-1.17M
Free Cash Flow	-211.47M
FCF Per Share	-$2.98

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VERA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.89%
Shareholder Yield	-22.89%
Earnings Yield	-7.63%
FCF Yield	-6.40%

Analyst Forecast

The average price target for VERA is $76.60, which is 64.70% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$76.60
Price Target Difference	64.70%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1